Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05641-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Sara Abdolmaleki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia. sara.abdolmaleki19@gmail.com. Hauptthemen laut MEDLINE: Copper, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 107-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Copper is a necessary micronutrient for maintaining the well-being of the human body. The biological activity of organic ligands, especially their anticancer activity, is often enhanced when they coordinate with copper(I) and (II) ions. Copper and its compounds are capable of inducing tumor cell death through various mechanisms of action, including activation of apoptosis signaling pathways by reactive oxygen species (ROS), inhibition of angiogenesis, induction of cuproptosis, and paraptosis. Some of the copper complexes are currently being evaluated in clinical trials for their ability to map tumor hypoxia in various cancers, including locally advanced rectal cancer and bulky tumors. Several studies have shown that copper nanoparticles can be used as effective agents in chemodynamic therapy, phototherapy, hyperthermia, and immunotherapy. Despite the promising anticancer activity of copper-based compounds, their use in clinical trials is subject to certain limitations. Elevated copper concentrations may promote tumor growth, angiogenesis, and metastasis by affecting cellular processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia. sara.abdolmaleki19@gmail.com.
- Pharmaceutical Sciences Research Center, Health Institute, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Department of Pharmaceutical Chemistry, School of Science and Technology, The University of Georgia, Tbilisi, Georgia. Samadkhaksar@yahoo.com.
Zitieren
APA
Abdolmaleki, S., Aliabadi, A., & Khaksar, S. (2024). Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05641-5
Vancouver
Abdolmaleki S, Aliabadi A, Khaksar S. Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05641-5
BibTeX
@article{Abdolmaleki2024,
author = {Abdolmaleki, Sara and Aliabadi, Alireza and Khaksar, Samad},
title = {Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05641-5}
}
EUVIMED